EMA issues guidance on interaction with notified bodies on combination advanced therapies
This article was originally published in RAJ Devices
Executive Summary
The European Medicines Agency has released for consultation guidance on how the agency's Committee for Advanced Therapies will interact with notified bodies when the committee assesses combination advanced therapy medicinal products that incorporate medical devices.